SGHT

insider transactions

Sight Sciences, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-85.8K

14.1K buy · 99.9K sell

Net value · 90d

-$308.2K

$68.8K in · $377.0K out

Sentiment · 90d

Net selling

15% buying · 85% selling

Open-market trades · 90d

14.1K buy · 99.9K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 17, 26

Tamara Fountain

Director

—

37.0K sh

Own +104%
Buy·P
Jun 10, 26

Staffan Encrantz

Director, 10% Owner

$68.8K

14.1K sh · $4.88

Own +1%
Grant·A
Jun 4, 26

Donald Zurbay

Director

$0

28.3K sh

Own +17%
Grant·A
Jun 4, 26

Catherine Mazzacco

Director

$0

28.3K sh

Own +69%
Grant·A
Jun 4, 26

Tamara Fountain

Director

$0

28.3K sh

Own +35%
Grant·A
Jun 4, 26

Staffan Encrantz

Director, 10% Owner

$0

28.3K sh

Own +2%
Grant·A
Jun 4, 26

Gerhard F Burbach

Director

$0

28.3K sh

Own +30%
Sell·S
May 18, 26

Alison Bauerlein

Chief Operating Officer · 10b5-1

$65.2K

12.7K sh · $5.12

Own -2%
Sell·S
Apr 6, 26

James Rodberg KEY

Chief Financial Officer · 10b5-1

$25.7K

7.2K sh · $3.55

Own -3%
Sell·S
Apr 6, 26

Jeremy B. Hayden

Chief Legal Officer · 10b5-1

$48.9K

13.8K sh · $3.55

Own -4%
Sell·S
Apr 2, 26

Alison Bauerlein

Chief Operating Officer · 10b5-1

$90.0K

25.9K sh · $3.48

Own -4%
Sell·S
Apr 2, 26

David Badawi

Chief Technology Officer · 10b5-1

$28.4K

8.2K sh · $3.48

Own -0%
Sell·S
Apr 1, 26

Brenton Taylor

EVP, Operations & R&D · 10b5-1

$10.6K

2.9K sh · $3.70

Own -1%
Sell·S
Apr 1, 26

Paul Badawi KEY

President and CEO · 10b5-1

$108.2K

29.2K sh · $3.70

Own -0%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	Tamara Fountain	Director	Grant A	37.0K	+104%	—	—
Jun 10, 2026	Staffan Encrantz	Director, 10% Owner	Buy P	14.1K	+1%	$4.88	$68.8K
Jun 4, 2026	Donald Zurbay	Director	Grant A	28.3K	+17%	—	$0
Jun 4, 2026	Catherine Mazzacco	Director	Grant A	28.3K	+69%	—	$0
Jun 4, 2026	Tamara Fountain	Director	Grant A	28.3K	+35%	—	$0
Jun 4, 2026	Staffan Encrantz	Director, 10% Owner	Grant A	28.3K	+2%	—	$0
Jun 4, 2026	Gerhard F Burbach	Director	Grant A	28.3K	+30%	—	$0
May 18, 2026	Alison Bauerlein 10b5-1	Chief Operating Officer	Sell S	12.7K	-2%	$5.12	$65.2K
Apr 6, 2026	James Rodberg KEY 10b5-1	Chief Financial Officer	Sell S	7.2K	-3%	$3.55	$25.7K
Apr 6, 2026	Jeremy B. Hayden 10b5-1	Chief Legal Officer	Sell S	13.8K	-4%	$3.55	$48.9K
Apr 2, 2026	Alison Bauerlein 10b5-1	Chief Operating Officer	Sell S	25.9K	-4%	$3.48	$90.0K
Apr 2, 2026	David Badawi 10b5-1	Chief Technology Officer	Sell S	8.2K	-0%	$3.48	$28.4K
Apr 1, 2026	Brenton Taylor 10b5-1	EVP, Operations & R&D	Sell S	2.9K	-1%	$3.70	$10.6K
Apr 1, 2026	Paul Badawi KEY 10b5-1	President and CEO	Sell S	29.2K	-0%	$3.70	$108.2K

About SGHT insider trading

This page tracks insider transactions for Sight Sciences, Inc. (SGHT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.